CLS Holdings USA, Inc. Contracts & Agreements

184 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Secured Promissory Note to FK Legacy Trust ($125,000)
CLS Holdings USA, Inc.
Pharmaceuticals
2025
Supplemental Indenture dated December 27, 2024 to Debenture Indenture dated December 12, 2018, as supplemented on March 31, 2021, supplemented on September 15, 2022, and as...
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2024
Amended Convertible Promissory Note made by CLS Holdings, Inc. in favor of FK Legacy Trust
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Redemption Agreement dated September 3, 2024, by and among the Company, Navy Capital Green Fund, L.P., Navy Capital Green Co-Invest Fund, LLC, and Navy Capital Green Holdings II,...
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Convertible Promissory Note to FK Legacy Trust ($2,600,000)
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Amended Glashow Employment Agreement effective June 12, 2024, by and between the Company and Andrew Glashow
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Golden Parachute Agreement effective June 12, 2024, by and between the Company and Andrew Glashow
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Amended Dickson Employment Agreement effective June 12, 2024, by and between the Company and Jamie Dickson
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Golden Parachute Agreement effective June 12, 2024, by and between the Company and Jamie Dickson
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Secured Promissory Note dated February 22, 2024, made by the Company in favor of FK Legacy Trust
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Secured Promissory Note dated February 22, 2024, made by the Company in favor of Patrick Haldan
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Secured Promissory Note dated February 22, 2024, made by the Company in favor of LEM Investments LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Secured Promissory Note dated February 22, 2024, made by the Company in favor of Ian Whitmore
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Redemption Agreement dated February 22, 2024, by and among the Company, Tribeca Investment Partners PTY LTD Tribeca Global Natural Resources Fund and the other parties named...
Investment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Employment Agreement effective February 1, 2024, by and between the Company and Andrew Glashow
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Employment Agreement effective February 1, 2024, by and between the Company and Charlene Magee
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Employment Agreement effective February 1, 2024, by and between the Company and Jamie Dickson
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Employment Agreement effective February 1, 2024, by and between the Company and Joseph Ramalho
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
CLS Holdings USA, Inc. 2024 Equity Incentive Plan
Bonus & Incentive Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Form of Unsecured Debenture
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Form of Secured Promissory Note
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Third Amended and Restated Debenture dated December 29, 2023, by and between the Company and Navy Capital Green Fund, LP
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Third Amended and Restated Debenture dated December 29, 2023, by and between the Company and Navy Capital Green Co-Invest Fund, LLC
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Third Amendment to Subscription Agreement dated December 29, 2023, by and between the Company and Navy Capital Green Fund, LP
Subscription Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Third Amendment to Subscription Agreement dated December 29, 2023, by and between the Company and Navy Capital Green Co-Invest Fund, LLC
Subscription Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Supplemental Indenture dated December 28, 2028 to Debenture Indenture dated December 12, 2018, as supplemented on March 31, 2021, and as further supplemented on September 15,...
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2024
Notice of Amendment of Warrant Terms
Warrant Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2024
Form of Unsecured Debenture
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Graham Saunders in the principal amount of $250,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Ian Whitmore in the principal amount of $250,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Tribeca Investment Partners in the principal amount of $500,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Tribeca Investment Partners in the principal amount of $500,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
AMENDED AND RESTATED UNSECURED DEBENTURE
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Navy Capital Green Fund LP in the principal amount of $500,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Text of public announcement issued April 10, 2023
CLS Holdings USA, Inc.
Pharmaceuticals
2023
Employment Agreement dated March 1, 2023 between CLS Holdings USA Inc. and Andrew Glashow
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Supplemental Indenture dated September 15, 2022 to Debenture Indenture dated December 12, 2018, as supplemented on March 31, 2021, by and between the Company and Odyssey Trust...
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Supplemental Indenture dated September 15, 2022 to Warrant Indenture dated December 12, 2018, as supplemented on March 31, 2021, by and between the Company and Odyssey Trust...
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Second Amendment to Subscription Agreement, dated September 15, 2022, by CLS Holdings USA, Inc., in favor Navy Capital Green Fund, LP
Subscription Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Second Amendment to Subscription Agreement, dated September 15, 2022, by CLS Holdings USA, Inc., in favor Navy Capital Green Co-Invest Fund, LLC
Subscription Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Second Amended and Restated Convertible Debenture, dated September 15, 2022, issued to Navy Capital Green Fund, LP
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2022
Second Amended and Restated Convertible Debenture, dated September 15, 2022, issued to Navy Capital Green Co-Invest Fund, LLC
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2022
Form of Warrant
Warrant Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Description of Registrants Securities
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Right to Use Land Agreement effective May 17, 2022 between DeWayne Brown and CLS Nevada, Inc
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2022
Third Amendment dated August 17, 2022 to Employment Agreement dated June 6, 2019 between Alternative Solutions, LLC and Charlene Soco
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Third Amendment to Employment Agreement, dated August 16, 2022, by and between CLS Holdings USA, Inc. and Andrew Glashow
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Employment Agreement dated June 6, 2019 between Alternative Solutions, LLC and Charlene Soco
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2022
First Amendment dated October 27, 2021 to Employment Agreement dated June 6, 2019 between Alternative Solutions, LLC and Charlene Soco
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Second Amendment February 4, 2022 to Employment Agreement dated June 6, 2019 between Alternative Solutions, LLC and Charlene Soco
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Clarification to Second Amendment to Employment Agreement for Employee Charlene Soco dated May 19, 2022 by and among Alternative Solutions, LLC, CLS Holidngs, USA, Inc., and...
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Second Amendment to Employment Agreement, dated April 25, 2022 but effective May 1, 2022, by and between CLS Holdings USA, Inc. and Jeffrey I. Binder
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Second Amendment to Employment Agreement, dated April 25, 2022 but effective May 1, 2022, by and between CLS Holdings USA, Inc. and Andrew Glashow dated April 25, 2022
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Form of Debenture issued in connection with the November 2021 Debenture Offering
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2022
Form of Warrant issued in connection with the November 2021 Debenture Offering
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Management Services Agreement dated October 20, 2021, by and among Kealii Okamalu, LLC, CSI Health MCD LLC, and the Fort McDermitt Cannabis Commission
Management Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Description of Registrants Securities
CLS Holdings USA, Inc.
Pharmaceuticals
2021
Third Amendment dated June 9, 2020 to Standard Industrial/Commercial Single-Tenant Lease by and between SFC Leasing, LP and Serenity Wellness Growers, LLC dated December 3, 2015,...
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2021
Secured Promissory Note, dated June 11, 2021, issued by In Good Health Inc. in favor of CLS Holdings USA, Inc. in the original principal amount of $3,000,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2021
First Amendment to Subscription Agreement, dated April 15, 2021, by CLS Holdings USA, Inc. in favor of Navy Capital Green Fund, LP
Subscription Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2021
First Amendment to Subscription Agreement, dated April 15, 2021, by CLS Holdings USA, Inc. in favor of Navy Capital Green Co-Invest Fund, LLC
Subscription Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2021
First Amendment to Subscription Agreement, dated April 19, 2021, by CLS Holdings USA, Inc. in favor of Darling Capital, LLC
Subscription Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2021
Amended and Restated Convertible Debenture, dated April 15, 2021, issued to Navy Capital Green Fund, LP in the principal amount of $1,126,114
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Amended and Restated Convertible Debenture, dated April 15, 2021, issued to Navy Capital Green Co-Invest Fund, LLC in the principal amount of $4,504,457
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Amended and Restated Convertible Debenture, dated April 19, 2021, issued to Darling Capital, LLC in the principal amount of $599,101
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Form of Warrant
Warrant Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2021
Supplemental Indenture dated March 31, 2021 to Debenture Indenture dated December 12, 2018 by and between the Company and Odyssey Trust Company
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2021
Supplemental Indenture dated March 31, 2021 to Warrant Indenture dated December 12, 2018 by and between the Company and Odyssey Trust Company
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2021
Description of Registrants Securities
CLS Holdings USA, Inc.
Pharmaceuticals
2020
Lease Addendum dated June 13, 2018 to Lease Agreement by and between 1800 Industrial, L.L.C. and Alternative Solutions, L.L.C. dated July 6, 2014
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2020
Lease Agreement by and between 1800 Industrial, LLC and CLS Nevada Inc. dated February 1, 2019 for premises located at 1800 Industrial Road, Suite 100
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2020
Lease Agreement by and between 1800 Industrial, LLC and CLS Nevada Inc. dated February 1, 2019 for premises located at 1718 Industrial Road
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2020
Lease Addendum dated February 25, 2020 to Leases dated July 6, 2014 and February 1, 2019 for or premises located at 1800 Industrial Road, Suites 100, 102, 160 and 180
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2020
Amendment to Employment Agreement, dated October 14, 2019 but effective October 1, 2019, by and among CLS Holdings, Inc., CLS Labs, Inc. and Jeffrey I. Binder
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2019
Amendment to Employment Agreement, dated October 14, 2019 but effective October 1, 2019, by and among CLS Holdings USA, Inc., and Andrew Glashow
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2019
First Amendment to Secured Promissory Note and Security Agreement and Termination of Membership Interest Purchase Agreement, dated August 26, 2019, by and among CannAssist and CLS...
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2019
First Amendment to Option Agreement, dated August 26, 2019, by and among CLS Massachusetts, Inc., CLS Holdings USA, Inc., and In Good Health, Inc
CLS Holdings USA, Inc.
Pharmaceuticals
2019
Form of First Amendment to Convertible Debenture
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2019
First Amendment to Employment Agreement, dated May 14, 2019, by and between CLS Nevada, Inc. and Don Decatur
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2019
Employment Agreement, dated April 8, 2019, by and between Alternative Solutions, LLC and Gregg Carlson
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2019
Membership Interest Purchase Agreement, dated March 11, 2019, by and among CLS Massachusetts, Inc., CannAssist, LLC, the Members of CannAssist, LLC party thereto, and David Noble,...
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
MA
2019
Employment Agreement dated March 1, 2019 between CLS Holdings USA, Inc. and Andrew Glashow
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2019
Loan Agreement, dated January 29, 2019, by and between CLS Holdings USA, Inc. and CannAssist, LLC
Loan Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
MA
2019
Secured Promissory Note, dated January 29, 2019, issued by CannAssist, LLC in favor of CLS Holdings USA, Inc
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2019
Security Agreement, dated January 29, 2019, by and between CLS Holdings USA, Inc. and CannAssist, LLC
Security Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
MA
2019
Debenture Indenture dated December 12, 2018 by and between the Company and Odyssey Trust Company
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Warrant Indenture dated December 12, 2018 by and between the Company and Odyssey Trust Company
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Agency Agreement dated December 12, 2018 by and between the Company and Canaccord Genuity Corp
Agency Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Form of Subscription Agreement and Warrant
Warrant Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Option Agreement, dated October 31, 2018, by and among CLS Holdings USA, Inc., CLS Massachusetts, Inc. and In Good Health, Inc. (Schedules and exhibits have been omitted pursuant...
CLS Holdings USA, Inc.
Pharmaceuticals
MA
2018
Loan Agreement, dated October 31, 2018, by and between CLS Holdings USA, Inc. and In Good Health, Inc
Loan Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
MA
2018
Secured Promissory Note, dated October 31, 2018, issued by In Good Health, Inc. in favor of CLS Holdings USA, Inc
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Security Agreement, dated October 31, 2018, by and between CLS Holdings USA, Inc. and In Good Health, Inc
Security Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
MA
2018
Lease Agreement by and between 1800 Industrial, LLC and Alternative Solutions, L.L.C dated July 6, 2014
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Standard Industrial/Commercial Single-Tenant Lease by and between SFC Leasing, LP and Serenity Wellness Growers, LLC dated December 3, 2015, as amended by that certain First...
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Convertible Promissory Note dated August 6, 2018 in favor of Newcan Investment Partners LLC in the original principal amount of $75,000.00
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Subscription Agreement and Form of Warrant
Warrant Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Employment Agreement dated July 31, 2018 between CLS Nevada, Inc. and Benjamin Sillitoe
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Employment Agreement dated July 31, 2018 between CLS Nevada, Inc. and Don Decatur
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Bonus Award Letter to Star Associates, LLC dated July 24, 2018
Bonus & Incentive Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Convertible Debenture dated July 20, 2018 in the original principal amount of $500,000 made by CLS Holdings USA, Inc. in favor of YA II PN, Ltd
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Warrant to Purchase 1,250,000 shares of Common Stock issued July 20, 2018 by CLS Holdings USA, Inc. in favor of YA II PN, Ltd
Warrant Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NJ
2018
Indemnification Agreement by and between CLS Holdings USA, Inc. and David Lamadrid dated June 28, 2018
Indemnification Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Indemnification Agreement by and between CLS Holdings USA, Inc. and Andrew Glashow dated June 28, 2018
Indemnification Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
6% Secured Promissory Note of CLS Holdings USA, Inc. in favor of Serenity Wellness Enterprises, LLC, as nominee, in the aggregate principal amount of $4,000,000 dated June 27, 2018
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Special Warrant Indenture dated June 20, 2018 between CLS Holdings USA, Inc. and Odyssey Trust Company
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Warrant Indenture dated June 20, 2018 between CLS Holdings USA, Inc. and Odyssey Trust Company
Indenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Agency Agreement dated June 20, 2018 by and between CLS Holdings USA, Inc. and Canaccord Genuity Corp
Agency Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Fifth Amendment to the Membership Interest Purchase Agreement by and between CLS Holdings USA, Inc. and Alternative Solutions, LLC effective as of May 17, 2018
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Securities Purchase Agreement dated May 11, 2018 by and between CLS Holdings USA, Inc. and YA II PN, Ltd
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NJ
2018
Convertible Debenture dated May 14, 2018 in the original principal amount of $750,000 made by CLS Holdings USA, Inc. in favor of YA II PN, Ltd
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Warrant to Purchase 1,875,000 shares of Common Stock issued May 14, 2018 by CLS Holdings USA, Inc. in favor of YA II PN, Ltd
Warrant Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NJ
2018
Registration Rights Agreement dated May 11, 2018 by and between CLS Holdings USA, Inc. and YA II PN, Ltd
Registration Rights Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NJ
2018
Convertible Promissory Note dated April 6, 2018 in favor of Jeffrey Binder in the original principal amount of $37,500.00
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Third Amendment to the Membership Interest Purchase Agreement by and between CLS Holdings USA, Inc. and Alternative Solutions, LLC effective as of March 27, 2018
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Fourth Amendment to the Membership Interest Purchase Agreement by and between CLS Holdings USA, Inc. and Alternative Solutions, LLC effective as of March 27, 2018
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Convertible Promissory Note dated February 20, 2018 in the original principal amount of $31,250 made by CLS Holdings USA, Inc. in favor of David Lamadrid
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2018
Securities Purchase Agreement dated February 20, 2018 by and between CLS Holdings USA, Inc. and David Lamadrid
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note dated February 12, 2018 in the original principal amount of $55,000 made by CLS Holdings USA, Inc. in favor of Efrat Investments LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2018
Securities Purchase Agreement dated February 12, 2018 by and between CLS Holdings USA, Inc. and Efrat Investments LLC
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note dated February 5, 2018 in the original principal amount of $550,000 made by CLS Holdings USA, Inc. in favor of Darling Capital LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2018
Securities Purchase Agreement dated February 5, 2018 by and between CLS Holdings USA, Inc. and Darling Capital LLC
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2018
Second Amendment to the Membership Interest Purchase Agreement by and between CLS Holdings USA, Inc. and Alternative Solutions, LLC dated January 25, 2018
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
First Amendment to the Membership Interest Purchase Agreement by and between CLS Holdings USA, Inc. and Alternative Solutions, LLC dated January 16, 2018
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Omnibus Amendment to Convertible Notes dated January 10, 2018, effective December 1, 2017, among CLS Holdings USA, Inc., Jeffrey I. Binder and Newcan Investment Partners, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Convertible Promissory Note dated January 5, 2018 in favor of Newcan Investment Partners LLC in the original principal amount of $115,000.00
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Convertible Promissory Note dated January 5, 2018 in favor of Jeffrey Binder in the original principal amount of $165,360.19
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Membership Interest Purchase Agreement dated December 4, 2017 between CLS Holdings USA, Inc. and Alternative Solutions, LLC
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2017
Employment Agreement dated November 30, 2017 between CLS Holdings USA, Inc. and David Lamadrid
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2017
Senior Convertible Promissory Note dated November 15, 2017 in the original principal amount of $363,000 made by CLS Holdings USA, Inc. in favor of FirstFire Global Opportunities...
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2017
Securities Purchase Agreement dated November 15, 2017 by and between CLS Holdings USA, Inc. and FirstFire Global Opportunities Fund, LLC
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2017
Convertible Promissory Note dated October 9, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $29,999.50
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated October 9, 2017 in favor of Jeffrey Binder in the original principal amount of $39,520.56
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Exchange Agreement dated September 20, 2017 between CLS Holdings USA, Inc. and StarForce Media, Inc
Exchange Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2017
Exchange Agreement dated September 25, 2017 between CLS Holdings USA, Inc. and Andrew J. Glashow, as representative and nominee
Exchange Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2017
Amendment #5 to Convertible Promissory Note Issued on March 18, 2016, effective July 15, 2017, by and between CLS Holdings USA, Inc. and Old Main Capital, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated August 23, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $621,658
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated August 23, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $70,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated August 23, 2017 in favor of Jeffrey Binder in the original principal amount of $115,050
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated August 23, 2017 in favor of Jeffrey Binder in the original principal amount of $72,767
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Amendment #4 to Convertible Promissory Note Issued on March 18, 2016, effective June 30, 2017, by and between CLS Holdings USA, Inc. and Old Main Capital, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Omnibus Loan Amendment Agreement, dated May 31, 2017, by and among CLS Holdings USA, Inc., Jeffrey I. Binder, Frank Koretsky, Newcan Investment Partners LLC and CLS CO 2016 LLC
Loan Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2017
Convertible Promissory Note dated March 31, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $120,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated March 31, 2017 in favor of Jeffrey Binder in the original principal amount of $159,500
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Amendment #3 to the Convertible Promissory Notes Issued on March 18, April 22 and May 27, 2016, dated March 27, 2017, by and between CLS Holdings USA, Inc. and Old Main Capital,...
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated January 10, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $410,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated January 10, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $50,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Amendment #2 to the Convertible Promissory Notes Issued on March 18, April 22 and May 27, 2016, dated November 28, 2016, by and between CLS Holdings USA, Inc. and Old Main...
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated August 3, 2016, in favor of CLS CO 2016, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Amendment to Agreements dated October 6, 2016 by and between CLS Holdings USA, Inc. and Old Main Capital, LLC
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Amendment to Equity Purchase Agreement dated October 6, 2016 by and between CLS Holdings USA, Inc. and Old Main Capital, LLC
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated January 12, 2016 in favor of Frank Koretsky
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated January 12, 2016, in favor of Jeffrey Binder
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated July 20, 2016 in favor of Frank Koretsky in the original principal amount of $210,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated July 20, 2016 in favor of Jeffrey Binder in the original principal amount of $262,750
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Securities Purchase Agreement dated March 18, 2016 between the Company and Old Main Capital, LLC
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2016
Equity Purchase Agreement dated April 18, 2016 by and between CLS Holdings USA, Inc. and Old Main Capital, LLC
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2016
Convertible Promissory Note dated April 11, 2016 in favor of Frank Koretsky in the original principal amount of $380,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated April 11, 2016 in favor of Jeffrey Binder in the original principal amount of $42,500
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Promissory Note dated March 18, 2016 in the original principal amount of $222,222 by CLS Holdings USA, Inc. in favor of Old Main Capital, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2016
Promissory Note dated March 18, 2016 in the original principal amount of $200,000 by CLS Holdings USA, Inc. in favor of Old Main Capital, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2016
Securities Purchase Agreement dated March 18, 2016 by and between CLS Holdings USA, Inc. and Old Main Capital, LLC
Purchase Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2016
Registration Rights Agreement dated March 18, 2016 by and between CLS Holdings USA, Inc. and Old Main Capital, LLC
Registration Rights Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated January 12, 2016 in favor of Frank Koretsky in the original principal amount of $895,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated January 12, 2016 in favor of Jeffrey Binder in the original principal amount of $50,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Form of Indemnification Agreement
Indemnification Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2015
Employment Agreement between CLS Holdings USA, Inc. and Alan Bonsett dated August 18, 2015
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2015
Loan Agreement dated April 29, 2015
Loan Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2015
Agreement and Plan of Merger dated April 29, 2015 by and among CLS Holdings USA, Inc., CLS Merger, Inc., and CLS Labs, Inc
Merger Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2015
Form of Stock Certificate
Stock Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2015
Employment Agreement dated October 1, 2014 between CLS Labs, Inc. and Jeffrey Binder
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2015
Addendum to Employment Agreement dated April 28, 2015 between CLS Labs, Inc., CLS Holdings USA, Inc. and Jeffrey Binder
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2015
Employment Agreement dated October 1, 2014 between CLS Labs, Inc. and Michael Abrams
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2015
Addendum to Employment Agreement dated April 28, 2015 between CLS Labs, Inc., CLS Holdings USA, Inc. and Michael Abrams
Employment Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2015
Lease dated April 17, 2015 between Casimir-Quince, LLC, and CLS Labs Colorado, Inc
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2015
Sublease Agreement dated April 17, 2015 between CLS Labs Colorado, Inc. and Picture Rock Holdings, LLC
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2015
Licensing Agreement dated April 17, 2015 between CLS Labs Colorado, Inc. and Picture Rock Holdings, LLC
CLS Holdings USA, Inc.
Pharmaceuticals
CO
2015
Equipment Lease dated April 17, 2015 between CLS Labs Colorado, Inc. and Picture Rock Holdings, LLC
Lease Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
CO
2015
Restricted Stock Grant Agreement dated April 28, 2015 between CLS Holdings USA, Inc. and Michael Abrams
Stock Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2015
Subscription for Property Agreement dated July 16, 2014 between CLS Labs, Inc. and Raymond Keller
Subscription Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2015
Promissory Note dated April 17, 2015 between CLS Labs Colorado, Inc. and Picture Rock Holdings, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
CO
2015
Confidentiality, Non-Compete and Proprietary Rights Agreements dated July 16, 2014 between CLS Labs, Inc. and Raymond Keller
Non-Competition Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2015
AMENDED AND RESTATED ARTICLES OF INCORPORATION OF CLS HOLDINGS USA,INC. ARTICLE I
Articles of Amendment
CLS Holdings USA, Inc.
Pharmaceuticals
2014
BYLAWS OF CLS HOLDINGS USA, INC. ARTICLE I. OFFICES
CLS Holdings USA, Inc.
Pharmaceuticals
2014